146305-34-2Relevant academic research and scientific papers
Synthesis and anticonvulsant activity of new N-(alkyl/Sub-stituted aryl)-N'-[4-(5-cyclohexylamino)-1,3,4-thiadiazole-2-ylphenyl]thioureas
Karakus, Sevgi,Kocyigit-Kaymakcioglu, Bedia,Toklu, Hale Z.,Aricioglu, Feyza,Rollas, Sevim
scheme or table, p. 48 - 53 (2009/06/17)
A series of novel thiourea derivatives carrying the 5-cylohexylamino-1,3,4- thiadiazole moiety was synthesized and their anticonvulsant activity was evaluated. Structures of the synthesized compounds have been confirmed by IR, 1H-NMR, and eleme
Synthesis of some 3-(Arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2, 4-triazole derivatives and their anticonvulsant activity
Kuecuekguezel, Ilkay,Gueniz Kuecuekguezel,Rollas, Sevim,Oetuek-Sanis, Guelten,Oezdemir, Osman,Bayrak, Ibrahim,Altug, Tuncay,Stables, James P.
, p. 893 - 901 (2007/10/03)
A series of novel 3-{[(substituted phenyl)methyl]thio}-4-alkyl/aryl-5-(4- aminophenyl)-4H-1,2,4-triazoles 11-20 and several related Schiff's bases, 3-{[(substituted phenyl)-methyl]thio}-4-alkyl/aryl-5-{[[(substituted phenyl/5-nitro-2-furyl)methylene]amino
Synthesis and antituberculosis activity of new N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl] thioureas
Karakus,Rollas
, p. 577 - 581 (2007/10/03)
In this study, eight original N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl] thiourea derivatives were synthesized and tested for antituberculosis activity. Antituberculosis activities of the synthesized compounds were screened in vitro
Some 3-Thioxo/Alkylthio-1,2,4-triazoles with a Substituted Thiourea Moiety as Possible Antimycobacterials
Kuecuekguezel, Ilkay,Kuecuekguezel, S. Gueniz,Rollas, Sevim,Kiraz, Muammer
, p. 1703 - 1708 (2007/10/03)
A series of novel N-alkyl/aryl-N'-[4-(4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thione-5-yl)phenyl]thioureas 1-19 and three S-alkylated representatives of the former, N-alkyl/aryl-N'-[4-(3-aralkylthio-4-alkyl/aryl-4H-1,2,4-triazole-5-yl)phenyl]thioureas 20-22, were synthesized and tested for antimycobacterial activity against Mycobacterium tuberculosis H37Rv as well as Mycobacterium fortuitum ATCC 6841 which is a rapid growing opportunistic pathogen. Compounds 4 and 9-11 were found to possess the same MIC value with that of Tobramycin against M. fortuitum ATCC 6841 whereas 1-3 and 21 had positive response against M. tuberculosis H37Rv at varying degrees. Compound 21 was identified as the most potent derivative of the 1-22 series by an MIC value of 6.25 μg/ml and selectivity index of 1.6
